NexGen Biofuels Ltd. (Nasdaq: NXGN) Announces Receipt of Nasdaq Delisting Determination
February 27 2008 - 11:43AM
PR Newswire (US)
NEW YORK, February 27 /PRNewswire-FirstCall/ -- NexGen Biofuels
Ltd. (f/k/a Healthcare Technologies Ltd.) (the "Company") announced
today that on February 26, 2008, the Company received a letter from
the Nasdaq Listing Qualification Panel, informing the Company that
the Panel had determined to delist the Company's ordinary shares
from The Nasdaq Stock Market following a determination by the Staff
of the Nasdaq Listing Qualifications Department that the Company
had failed to meet the Nasdaq listing standards for a reverse
merger in connection with the Company's Plan of Arrangement with
NexGen Biofuels Inc. Nasdaq will suspend trading of the Company's
ordinary shares effective at the open of business on Thursday,
February 28, 2008. The Company believes that, following the recent
filing of a Form 211 by a market maker, its ordinary shares will be
eligible for trading on the OTC Bulletin Board. For more
information on NexGen Biofuels, Inc., visit
http://www.nexgenbiofuels.net/. Safe harbor: This press release
contains certain forward looking statements within the meaning of
section 27a of the securities act of 1933 and section 21e of the
securities exchange act of 1934. With the exception of historical
information contained herein, the matters discussed in this press
release involve risk and uncertainties. Actual results could differ
materially from those expressed in any forward-looking statement
made by or on behalf of healthcare technologies ltd. Readers are
referred to the documents filed by the company with the securities
and exchange commission, specifically the form 8-k/a filed on
February 12, 2008 that identifies important risks which could cause
actual results to differ from those contained in the forward
looking statements. Contact: Eran Rotem CFO, +972-3-9277232
DATASOURCE: NexGen Biofuels Ltd CONTACT: Contact: Eran Rotem CFO,
+972-3-9277232
Copyright